Related Experiment Videos
Studies of intravenous cefoxitin (MK306)
The Medical Journal of Australia
|May 6, 1978
Summary
This study investigated cefoxitin, a cephamycin antibiotic, for surgical prophylaxis and treating infections. Cefoxitin demonstrated effectiveness in lung and urinary tract infections with a longer half-life than previously reported.
Area of Science:
- Pharmacology
- Infectious Diseases
- Surgical Prophylaxis
Background:
- Cefoxitin is a novel cephamycin antibiotic.
- The need for effective prophylactic and therapeutic antimicrobial agents is critical in surgical settings.
Purpose of the Study:
- To evaluate the pharmacokinetics of cefoxitin in patients undergoing hip replacement.
- To assess the efficacy and tolerability of cefoxitin in treating severe acute infections.
Main Methods:
- Pharmacokinetic analysis in six patients receiving cefoxitin for surgical prophylaxis.
- Efficacy assessment in nine patients with severe acute infections.
Main Results:
- The mean elimination half-life of cefoxitin was 83-87 minutes, longer than reported in other studies.
- Cefoxitin showed efficacy against susceptible organisms in lung and urinary tract infections.
- The antibiotic was well tolerated, with phlebitis noted in long-term therapy.
Conclusions:
- Cefoxitin exhibits favorable pharmacokinetic properties and clinical efficacy.
- Cefoxitin may be a valuable option for prophylactic use in orthopedic and bowel surgeries.
- Further research into cefoxitin's role in managing infections is warranted.